Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands

Gijs AA Hubben email, Jasper M Bos email, Christa A Veltman-Starkenburg email, Simon Stegmeijer email, Henrik W Finnern email, Bregt S Kappelhoff email, Kit N Simpson email, Andrea Tramarin email and Maarten J Postma email

Cost Effectiveness and Resource Allocation 2007, 5:15doi:10.1186/1478-7547-5-15

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.